Prothena (NASDAQ:PRTA) Rating Lowered to Neutral at Cantor Fitzgerald
Prothena (NASDAQ:PRTA – Get Free Report) was downgraded by research analysts at Cantor Fitzgerald from an “overweight” rating to a “neutral” rating in a research report issued to clients and investors on Tuesday, MarketBeat reports. Several other equities research analysts have also recently issued reports on PRTA. Royal Bank of Canada lowered their price objective […]
Prothena (NASDAQ:PRTA – Get Free Report) was downgraded by research analysts at Cantor Fitzgerald from an “overweight” rating to a “neutral” rating in a research report issued to clients and investors on Tuesday, MarketBeat reports. Several other equities research analysts have also recently issued reports on PRTA. Royal Bank of Canada lowered their price objective […]
